Literature DB >> 2504091

Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis.

R F Parker1, J K Davis, G H Cassell, H White, D Dziedzic, D K Blalock, R B Thorp, J W Simecka.   

Abstract

In C57BL/6N and C3H/HeN mice known to be free of all murine pathogens and matched for age, sex, microbiologic, and environmental factors, exposure to NO2 for 4 h prior to exposure to infectious aerosols of Mycoplasma pulmonis resulted in potentiation of murine respiratory mycoplasmosis (MRM). In the C57BL/6N mice, NO2 increased the incidence of death, incidence of gross lung lesions, and incidence of microscopic lung lesions, but did not increase the incidence of infection in the lungs. Nitrogen dioxide affected the C3H/HeN mice (a strain known to be more susceptible than the C57BL/6N strain to MRM) similarly, with the exception that the incidence of death and microscopic lesions were not affected in this strain at the concentrations of M. pulmonis used. Exposure to the oxidant also increased the severity of microscopic lesions and the numbers of Mycoplasma organisms in the lungs of both mouse strains. Thus, NO2 appeared to affect host lung defense mechanisms responsible for limiting the extent of infection. The NO2 exposure level required to produce potentiation varied with the genetic background of the host, the number of Mycoplasma organisms administered, and the end point measured. In further experiments in C57BL/6N mice, exposure to 5 or 10 ppm of NO2 for 4 h prior to infection with aerosolized, radiolabeled M. pulmonis reduced clearance of these organisms from the lungs over a 72-h time period. Nitrogen dioxide exposure did not change the rate of physical removal of Mycoplasma organisms from the lung. Reduced clearance was due to impaired intrapulmonary killing of Mycoplasma organisms in NO2-exposed mice.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504091     DOI: 10.1164/ajrccm/140.2.502

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.

Authors:  D T Crouse; G H Cassell; K B Waites; J M Foster; G Cassady
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.

Authors:  A L Yancey; H L Watson; S C Cartner; J W Simecka
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.

Authors:  J M Hickman-Davis; S M Michalek; J Gibbs-Erwin; J R Lindsey
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Resistance to mycoplasmal lung disease in mice is a complex genetic trait.

Authors:  S C Cartner; J W Simecka; D E Briles; G H Cassell; J R Lindsey
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Gaseous air pollutants and hospitalization for respiratory disease in the neonatal period.

Authors:  Robert E Dales; Sabit Cakmak; Marc Smith Doiron
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

9.  Infectious causes of chronic inflammatory diseases and cancer.

Authors:  G H Cassell
Journal:  Emerg Infect Dis       Date:  1998 Jul-Sep       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.